Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $86.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.92 | 3.41% Avg Daily Range (30 D): $0.04 | 2.66% Avg Daily Range (90 D): $0.07 | 4.10% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 84 Avg Trade Size (Sh.) (30 D): 166 Avg Trade Size (Sh.) (90 D): 172 Institutional Trades Total Inst.Trades: 1,906 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.06M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $1.06M Avg Closing Trade (90 D): $.95M Avg Closing Volume: 115.69K         News Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Mar 15, 2025 @ 3:25 PM Zentalis Pharmaceuticals Presents Updated Clinical... Source: N/A Mar 3, 2025 @ 10:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Feb 3, 2025 @ 10:42 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Jan 9, 2025 @ 12:00 PM Zentalis Pharmaceuticals Announces Azenosertib Fas... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.13 $-.67 $-.66 Diluted EPS $-3.13 $-.67 $-.66 Revenue $ 26.87M $ M $ 26.87M Gross Profit $ $ $ Net Income / Loss $ -224.19M $ -48.28M $ -47.47M Operating Income / Loss $ -212.05M $ -45.62M $ -49.85M Cost of Revenue $ $ $ Net Cash Flow $ 4.26M $ 8.03M $ -7.42M PE Ratio